{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:08:35Z","timestamp":1789495715908,"version":"build-2803163510"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Clinical Medical Research Center for Otology in Hunan Province","award":["2023SK4030"],"award-info":[{"award-number":["2023SK4030"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To establish a prognostic PANoptosis-related gene signature in HNSCC and elucidate the role of Down syndrome cell adhesion molecule (DSCAM) in regulating tumor progression and immune evasion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Differential expression and prognostic analyses were performed to define HNSCC subtypes based on PANoptosis-related genes. Least absolute shrinkage and selection operator (LASSO) Cox regression was applied to construct the HNSCPAN-index, which stratified patients into high- and low-risk groups. The predictive performance of this index was validated in independent cohorts. Associations with immune infiltration, mutation profiles, and drug sensitivity were also examined. Functional validation of DSCAM was conducted through in vitro and in vivo experiments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Six prognostically significant genes were identified and integrated into the HNSCPAN-index, which demonstrated independent prognostic value. Immunological landscape analysis showed that the low-risk group defined by the HNSCPAN-index was enriched in CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, follicular helper T cells, and memory-activated CD4\n                      <jats:sup>+<\/jats:sup>\n                      \u2009T cells. Consistently, immune, stromal, and microenvironmental scores were significantly higher in the low-risk group. DSCAM knockdown suppressed proliferation and migration of HNSCC cell lines. Knockdown of DSCAM promotes PANoptosis by inhibiting the activity of the PI3K\/AKT pathway. In vivo, DSCAM depletion inhibited tumor growth and enhanced CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell infiltration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The HNSCPAN-index may serve as a potential biomarker for prognostic stratification and prediction of therapeutic responses in HNSCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0344957","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:44:24Z","timestamp":1789494264000},"page":"e0344957","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["PANoptosis-based HNSCPAN-index predicts prognosis and reveals DSCAM as a therapeutic target in head and neck squamous cell carcinoma"],"prefix":"10.1371","volume":"21","author":[{"given":"Yekai","family":"Feng","sequence":"first","affiliation":[{"name":"Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University","place":["Changsha, Hunan, China"],"department":["The 2nd Department of Head and Neck Surgery, Department of Oncoplastic Surgery"]},{"name":"The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"],"department":["Department of Otorhinolaryngology Head and Neck Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghang","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"],"department":["Department of Otorhinolaryngology Head and Neck Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Ou","sequence":"additional","affiliation":[{"name":"Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University","place":["Changsha, Hunan, China"],"department":["The 2nd Department of Head and Neck Surgery, Department of Oncoplastic Surgery"]},{"name":"The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"],"department":["Department of Otorhinolaryngology Head and Neck Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglai","family":"Tang","sequence":"additional","affiliation":[{"name":"The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"],"department":["Department of Otorhinolaryngology Head and Neck Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Tang","sequence":"additional","affiliation":[{"name":"The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"],"department":["Department of Otorhinolaryngology Head and Neck Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zeng","sequence":"additional","affiliation":[{"name":"The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"],"department":["Operation Department"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[{"name":"Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University","place":["Changsha, Hunan, China"],"department":["Department of Anesthesia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"],"department":["Department of Otorhinolaryngology Head and Neck Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5874-6049","authenticated-orcid":true,"given":"Shisheng","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"],"department":["Department of Otorhinolaryngology Head and Neck Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"1","key":"pone.0344957.ref001","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and neck cancer","volume":"382","author":"LQM Chow","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0344957.ref002","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"DE Johnson","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"pone.0344957.ref003","doi-asserted-by":"crossref","DOI":"10.1093\/jpp\/rgaf093","article-title":"Key signalling pathways in head and neck squamous cell carcinoma: mechanisms and therapeutic targets","volume":"78","author":"E Bani-Ahmad","year":"2026","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"pone.0344957.ref004","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12935-025-03963-z","article-title":"Interferon signaling and STING pathway in head and neck cancers: unlocking immune secrets and therapeutic frontiers","volume":"25","author":"K Zolfaghari","year":"2025","journal-title":"Cancer Cell Int"},{"issue":"1","key":"pone.0344957.ref005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40364-022-00433-w","article-title":"Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma","volume":"11","author":"Y Xue","year":"2023","journal-title":"Biomark Res"},{"issue":"1","key":"pone.0344957.ref006","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/imr.13279","article-title":"PANoptosis: mechanisms, biology, and role in disease","volume":"321","author":"X Sun","year":"2024","journal-title":"Immunol Rev"},{"issue":"5","key":"pone.0344957.ref007","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"D Bertheloot","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"pone.0344957.ref008","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.csbj.2021.07.038","article-title":"From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways","volume":"19","author":"Y Wang","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"pone.0344957.ref009","doi-asserted-by":"crossref","first-page":"109019","DOI":"10.1016\/j.clim.2022.109019","article-title":"Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer","volume":"238","author":"H Pan","year":"2022","journal-title":"Clin Immunol"},{"issue":"1","key":"pone.0344957.ref010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-017-0553-x","article-title":"The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma","volume":"36","author":"X Feng","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"pone.0344957.ref011","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1038\/s41598-024-60441-8","article-title":"Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma","volume":"14","author":"P Yang","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0344957.ref012","article-title":"Epidermal growth factor protects squamous cell carcinoma against cisplatin-induced cytotoxicity through increased interleukin-1\u03b2 expression","volume":"8","author":"S-C Ko","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"pone.0344957.ref013","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41419-021-04011-0","article-title":"Afatinib induces pro-survival autophagy and increases sensitivity to apoptosis in stem-like HNSCC cells","volume":"12","author":"X Liu","year":"2021","journal-title":"Cell Death Dis"},{"issue":"2","key":"pone.0344957.ref014","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cell.2018.03.059","article-title":"SnapShot: TCGA-analyzed tumors","volume":"173","author":"A Blum","year":"2018","journal-title":"Cell"},{"key":"pone.0344957.ref015","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad965","article-title":"NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update","volume":"52","author":"E Clough","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"pone.0344957.ref016","doi-asserted-by":"crossref","first-page":"1218661","DOI":"10.3389\/fimmu.2023.1218661","article-title":"Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma","volume":"14","author":"J Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"pone.0344957.ref017","doi-asserted-by":"crossref","first-page":"1323199","DOI":"10.3389\/fimmu.2024.1323199","article-title":"Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification","volume":"15","author":"G Ouyang","year":"2024","journal-title":"Front Immunol"},{"key":"pone.0344957.ref018","doi-asserted-by":"crossref","first-page":"711020","DOI":"10.3389\/fonc.2021.711020","article-title":"Integration of scRNA-seq and bulk RNA-seq to analyse the heterogeneity of ovarian cancer immune cells and establish a molecular risk model","volume":"11","author":"L Liang","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0344957.ref019","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12967-023-04029-2","article-title":"Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets","volume":"21","author":"P Zhao","year":"2023","journal-title":"J Transl Med"},{"issue":"5","key":"pone.0344957.ref020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"G Yu","year":"2012","journal-title":"OMICS"},{"issue":"1","key":"pone.0344957.ref021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"M Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"pone.0344957.ref022","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","article-title":"Toward understanding the origin and evolution of cellular organisms","volume":"28","author":"M Kanehisa","year":"2019","journal-title":"Protein Sci"},{"key":"pone.0344957.ref023","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac963","article-title":"KEGG for taxonomy-based analysis of pathways and genomes","volume":"51","author":"M Kanehisa","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"pone.0344957.ref024","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"AM Newman","year":"2015","journal-title":"Nat Methods"},{"issue":"7693","key":"pone.0344957.ref025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"S Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"9","key":"pone.0344957.ref026","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.3390\/ijms21093196","article-title":"Short exposure to ethanol diminishes caspase-1 and ASC activation in human HepG2 cells in vitro","volume":"21","author":"J-A H\u00f6rauf","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0344957.ref027","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s10020-024-00891-y","article-title":"Caspase-11 signaling promotes damage to hippocampal CA3 to enhance cognitive dysfunction in infection","volume":"30","author":"N Liang","year":"2024","journal-title":"Mol Med"},{"issue":"1","key":"pone.0344957.ref028","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1038\/s41467-021-27619-4","article-title":"Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing","volume":"12","author":"CHL K\u00fcrten","year":"2021","journal-title":"Nat Commun"},{"issue":"7","key":"pone.0344957.ref029","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer","volume":"171","author":"SV Puram","year":"2017","journal-title":"Cell"},{"key":"pone.0344957.ref030","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10495-023-01931-4","article-title":"PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer","volume":"29","author":"Z Liu","year":"2024","journal-title":"Apoptosis"},{"issue":"1","key":"pone.0344957.ref031","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13046-024-03089-6","article-title":"Cell death shapes cancer immunity: spotlighting PANoptosis","volume":"43","author":"L Gao","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"pone.0344957.ref032","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12964-022-00854-y","article-title":"Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons","volume":"20","author":"A Naimi","year":"2022","journal-title":"Cell Commun Signal"},{"issue":"1","key":"pone.0344957.ref033","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11033-023-09097-7","article-title":"TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress","volume":"51","author":"K-L Zhu","year":"2024","journal-title":"Mol Biol Rep"},{"issue":"1","key":"pone.0344957.ref034","article-title":"GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels","volume":"24","author":"C-J Liu","year":"2023","journal-title":"Brief Bioinform"},{"issue":"3","key":"pone.0344957.ref035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40265-023-01835-2","article-title":"Treating head and neck cancer in the age of immunotherapy: a 2023 update","volume":"83","author":"A Bhatia","year":"2023","journal-title":"Drugs"},{"key":"pone.0344957.ref036","doi-asserted-by":"crossref","first-page":"975847","DOI":"10.3389\/fimmu.2022.975847","article-title":"NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment","volume":"13","author":"X-M Chen","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"pone.0344957.ref037","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.arcmed.2020.12.001","article-title":"Long noncoding RNA MIAT regulates the process of laryngeal squamous cell carcinoma through regulation of miR-147a\/BCOR","volume":"52","author":"D Song","year":"2021","journal-title":"Arch Med Res"},{"issue":"11","key":"pone.0344957.ref038","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005632","article-title":"Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition","volume":"10","author":"M Crist","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"6","key":"pone.0344957.ref039","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jimmun\/vkaf042","article-title":"Innate immune sensor NLRP3 drives PANoptosome formation and PANoptosis","volume":"214","author":"BR Sharma","year":"2025","journal-title":"J Immunol"},{"issue":"7","key":"pone.0344957.ref040","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial","volume":"17","author":"TY Seiwert","year":"2016","journal-title":"Lancet Oncol"},{"issue":"9","key":"pone.0344957.ref041","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3390\/cancers12092691","article-title":"Immunotherapy breakthroughs in the treatment of recurrent or metastatic head and neck squamous cell carcinoma","volume":"12","author":"C Borel","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"10212","key":"pone.0344957.ref042","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"B Burtness","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"pone.0344957.ref043","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1200\/JCO.22.02786","article-title":"Personalized biomarker-based umbrella trial for patients with recurrent or metastatic head and neck squamous cell carcinoma: KCSG HN 15-16 TRIUMPH Trial","volume":"42","author":"B Keam","year":"2024","journal-title":"J Clin Oncol"},{"issue":"2","key":"pone.0344957.ref044","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7150\/thno.91814","article-title":"Current evidence and therapeutic implication of PANoptosis in cancer","volume":"14","author":"DKW Ocansey","year":"2024","journal-title":"Theranostics"},{"issue":"7378","key":"pone.0344957.ref045","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"I Mellman","year":"2011","journal-title":"Nature"},{"key":"pone.0344957.ref046","doi-asserted-by":"crossref","first-page":"1275461","DOI":"10.3389\/fimmu.2023.1275461","article-title":"Metabolic reprogramming involves in transition of activated\/resting CD4+ memory T cells and prognosis of gastric cancer","volume":"14","author":"Y Sun","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0344957.ref047","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13287-022-02913-0","article-title":"Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer","volume":"13","author":"H Zheng","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"22","key":"pone.0344957.ref048","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1158\/0008-5472.CAN-16-3453","article-title":"PD-1 expression in head and neck squamous cell carcinomas derives primarily from functionally anergic CD4+ TILs in the presence of PD-L1+ TAMs","volume":"77","author":"AK Mattox","year":"2017","journal-title":"Cancer Res"},{"issue":"19","key":"pone.0344957.ref049","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"RL Ferris","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0344957.ref050","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","article-title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study","volume":"21","author":"A Marabelle","year":"2020","journal-title":"Lancet Oncol"},{"issue":"8","key":"pone.0344957.ref051","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41580-025-00842-3","article-title":"p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases","volume":"26","author":"Y Liu","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"key":"pone.0344957.ref052","first-page":"606759","article-title":"RIPK4 driven by TP53 mutations promotes resistance to redox stress of CRC by phosphorylating MTHFD1","volume":"2024","author":"L Yu","year":"2024","journal-title":"bioRxiv"},{"issue":"12","key":"pone.0344957.ref053","article-title":"DSCAM\/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome","volume":"131","author":"X-Y Tang","year":"2021","journal-title":"J Clin Invest"},{"issue":"21","key":"pone.0344957.ref054","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1158\/1078-0432.CCR-15-2724","article-title":"PAK1 is a novel therapeutic target in tyrosine kinase inhibitor-resistant lung adenocarcinoma activated by the PI3K\/AKT signaling regardless of EGFR mutation","volume":"22","author":"D-W Wu","year":"2016","journal-title":"Clin Cancer Res"},{"key":"pone.0344957.ref055","doi-asserted-by":"crossref","first-page":"114850","DOI":"10.1016\/j.expneurol.2024.114850","article-title":"Esculentoside H reduces the PANoptosis and protects the blood-brain barrier after cerebral ischemia\/reperfusion through the TLE1\/PI3K\/AKT signaling pathway","volume":"379","author":"K Zhang","year":"2024","journal-title":"Exp Neurol"},{"key":"pone.0344957.ref056","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/DDDT.S495225","article-title":"Exploring the anti-PANoptosis mechanism of dachaihu decoction against sepsis-induced acute lung injury: network pharmacology, bioinformatics, and experimental validation","volume":"19","author":"Z Yang","year":"2025","journal-title":"Drug Des Devel Ther"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:44:35Z","timestamp":1789494275000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344957"}},"subtitle":[],"editor":[{"given":"Kota V","family":"Ramana","sequence":"first","affiliation":[{"name":"Noorda College of Osteopathic Medicine","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0344957","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}